miR-133 Regulates Evi1 Expression in AML Cells as a Potential Therapeutic Target

Scientific Reports - United Kingdom
doi 10.1038/srep19204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Suppression of GPR56 Expression by Pyrrole-Imidazole Polyamide Represents a Novel Therapeutic Drug for AML With High EVI1 Expression

Scientific Reports
Multidisciplinary
2018English

Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2009English

miR‑494.3p Expression in Synovial Sarcoma: Role of CXCR4 as a Potential Target Gene

International Journal of Oncology
Cancer ResearchOncology
2018English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Cellular Senescence and Senescence‐associated T Cells as a Potential Therapeutic Target

Geriatrics and Gerontology International
MedicineGerontologyGeriatricsHealth
2019English

Integrative Bioinformatics Analysis Identifies ROBO1 as a Potential Therapeutic Target Modified by miR-218 in Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Mitochondrial Apoptotic Priming Regulates Therapeutic Responses in AML

Cancer Discovery
Oncology
2012English

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

cMET as a Potential Therapeutic Target in Gastric Cancer (Review)

International Journal of Molecular Medicine
MedicineGenetics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy